Literature DB >> 15030121

Proliferative vitreoretinopathy--at what risk is the fellow eye?

Sibylla Richter-Mueksch1, Christopher G Kiss, Wolfgang Radner, Susanne Binder, Michaela Velikay-Parel.   

Abstract

PURPOSE: To find out if patients with proliferative vitreoretinopathy (PVR) due to complicated retinal detachment are at risk to acquire the same disease or other vision-threatening retinal abnormalities in the fellow eye. To furthermore assess in what time-period they appear and if subgroups of patients have special risks.
METHODS: 100 consecutive PVR-patients were studied retrospectively. 21 patients with PVR graded lower than C3, traumatic PVR, diabetic retinopathy or congenital vitreoretinal diseases were excluded. Age, gender, best-corrected visual acuity at the first and last visit, refraction, ocular disease in both eyes and observation-time were recorded.
RESULTS: After a mean follow-up of 8.5 years, 42 of 79 patients (53.4%) showed vision-threatening abnormalities in their fellow eyes: among them, 9 patients (11.4%) had PVR, 13 (16%) simple retinal detachments and 14 (17.3%) retinal breaks. Abnormalities in the fellow eye did not develop after a certain time following surgery of the primary eye; 71.4% appeared within 5 years. Aphakic and pseudophakic patients had retinal breaks significantly more often (p = 0.011) than phakic patients. Myopia did not increase the risk for any abnormality. Men developed retinal detachment (p = 0.037) and PVR (p = 0.025) significantly more often than women.
CONCLUSION: Patients with PVR have a greater than 50% risk of developing vision-threatening retinal abnormalities in their fellow eye. Because of this increased risk, these patients need regularly-scheduled long-term follow-up. SUMMARY STATEMENT: Patients with PVR have a greater than 50% risk of developing vision-threatening retinal abnormalities in their fellow eye and a 37% risk to develop PVR from rhegmatogenous retinal detachment. More than two thirds of abnormalities in the fellow eye developed within five years of surgery of the primary eye.

Entities:  

Mesh:

Year:  2004        PMID: 15030121     DOI: 10.1007/BF03040421

Source DB:  PubMed          Journal:  Wien Klin Wochenschr        ISSN: 0043-5325            Impact factor:   2.275


  16 in total

1.  [Functional and anatomic results with intra-ocular tamponade in retinal detachment surgery].

Authors:  D Knaflic; U Mester
Journal:  Fortschr Ophthalmol       Date:  1990

2.  [Retinal detachment with posterior chamber lens].

Authors:  D Hünemohr; D T Pham; J Wollensak
Journal:  Klin Monbl Augenheilkd       Date:  1992-02       Impact factor: 0.700

3.  Vitreoretinal surgery outcomes. Impact on bilateral visual function.

Authors:  I U Scott; W E Smiddy; A Merikansky; W Feuer
Journal:  Ophthalmology       Date:  1997-06       Impact factor: 12.079

4.  The development of severe proliferative vitreoretinopathy after retinal detachment surgery. Grade B: a determining risk factor.

Authors:  M Bonnet
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1988       Impact factor: 3.117

5.  [Myopia and detached retinas. Statistical analysis of 800 cases].

Authors:  T Kaufmann
Journal:  Ophthalmologica       Date:  1969       Impact factor: 3.250

6.  Treatment of retinal tears and lattice degenerations in fellow eyes in high risk patients suffering retinal detachment: a prospective study.

Authors:  L Mastropasqua; P Carpineto; M Ciancaglini; G Falconio; P E Gallenga
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

7.  Aphakic retinal detachment. Management of the fellow eye.

Authors:  W E Benson; M G Grand; E Okun
Journal:  Arch Ophthalmol       Date:  1975-04

8.  Classification of proliferative vitreoretinopathy used in the silicone study. The Silicone Study Group.

Authors:  J S Lean; W H Stern; A R Irvine; S P Azen
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

9.  [Outcome of the unaffected eye in retinal detachment. Study of 1148 patients].

Authors:  P Girard; L Goichot; J J Saragoussi; I Merad; A Forest
Journal:  J Fr Ophtalmol       Date:  1982       Impact factor: 0.818

10.  Clinical risk factors for proliferative vitreoretinopathy.

Authors:  M Cowley; B P Conway; P A Campochiaro; D Kaiser; H Gaskin
Journal:  Arch Ophthalmol       Date:  1989-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.